They joined us!
Date of creation: 09/05/2023
Number of employees: 3 salariés et 1 alternant
Locations / Sites of operation: Lyon 69005
Field of activity (biotech/medtech/digital healthtech) : healthtech
Who are they?
Andrew is a digital post-consultation follow-up solution that improves care adherence and patient understanding, while increasing the value of healthcare professionals’ services with 256 000 active patients and 1300 therapists.
It enables remote patient follow-up, allowing patients to receive their medical prescriptions after the consultation. Practitioners can monitor symptom progression and adherence day by day, communicate with patients via teleconsultation or secure messaging, and design evolving care pathways with progressive prescriptions over several weeks.
Andrew therefore enables healthcare professionals to break through the revenue and optimizing their therapeutic time.
Why did they join Lyonbiopole?
Andrew aims to join Lyonbiopole to collaborate with medical and pharmaceutical stakeholders on adherence and follow-up challenges in chronic conditions and complex treatments (multiple sclerosis, GLP-1 therapies, type 2 diabetes, oncology, and others).
Already deployed across 265,000 patients and 1,400 healthcare professionals, Andrew delivers an operational post-consultation follow-up solution with strong clinical and economic impact.
Damien Zivanovic CEO & Boris Gochgarian Président
